Clinical Trials Directory

Trials / Unknown

UnknownNCT04250779

Evaluating Efficacy of Smart Device in Assisting With Inhaler Technique and Adherence

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Landon Pediatric Foundation · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

Asthma affects over 10 million children in the U.S., and poses a significant health and cost burden. Metered dose inhaler (MDI) is the most common method of treatment. Studies show that up to 80% of patients demonstrate incorrect use of MDIs, which results in suboptimal medication delivery to the lungs. Asthma control can be followed by symptoms, rescue medication usage and measures of airflow obstruction. Current options to monitor control include an asthma diary (relies on consistent use by the patient), pharmacy records of medication dispensing (dispensing does not equal usage), and peak expiratory flow (PEF) meters (significant variability in technique leading to inconsistent results). CapMedic is a smart inhaler and home spirometer device which aims to assist with correct MDI usage and to monitor asthma control. CapMedic fits on top of the MDI inhaler and provides live audio-visual-haptic cues to guide the patient for correctly using their inhaler. CapMedic includes a built-in forced expiratory flow in 1 second (FEV1, a measure of airflow) and PEF meter. It will utilize the same audio-visual-haptic hardware to implement live cues that encourage patient's effort in performing accurate at-home FEV1/PEF test. Cap will also be able to log medication usage and Medic application will allow patients to keep an asthma symptom diary.

Detailed description

CapMedic is a smart inhaler and home spirometer device which aims to assist with correct MDI usage and to monitor asthma control. CapMedic fits on top of the MDI inhaler and provides live audio-visual-haptic cues to guide the patient for correctly using their inhaler. CapMedic includes a built-in forced expiratory flow in 1 second (FEV1, a measure of airflow) and PEF meter. It will utilize the same audio-visual-haptic hardware to implement live cues that encourage patient's effort in performing accurate at-home FEV1/PEF test. Cap will also be able to log medication usage and Medic application will allow patients to keep an asthma symptom diary.

Conditions

Interventions

TypeNameDescription
DEVICECapMedic smart inhaler deviceThe CapMedic device provides active coaching to promote correct and regular use of MDI.
BEHAVIORALVideo-based guidancePatients are shown a video of how to use inhalers correctly and any questions are answered by the clinician. They are also encouraged to use inhalers regularly and correctly at home.

Timeline

Start date
2019-07-01
Primary completion
2021-07-01
Completion
2021-12-01
First posted
2020-01-31
Last updated
2020-09-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04250779. Inclusion in this directory is not an endorsement.